Show simple item record

dc.contributor.authorKverme, Karen Obrestad
dc.contributor.authorHaugland, Gyri Teien
dc.contributor.authorHannisdal, Rita
dc.contributor.authorKallekleiv, Marielle
dc.contributor.authorColquhoun, Duncan John
dc.contributor.authorLunestad, Bjørn Tore
dc.contributor.authorWergeland, Heidrun Inger
dc.contributor.authorSamuelsen, Ole Bent
dc.PublishedKverme Ko, Haugland GT, Hannisdal R, Marielle, Colquhoun DJ, Lunestad BT, Wergeland HI, Samuelsen OB. Pharmacokinetics of florfenicol in lumpfish (Cyclopterus lumpus L.) after a single oral administration. Aquaculture. 2019;512:734279eng
dc.description.abstractFarming of lumpfish for biological removal of sea lice from farmed Atlantic salmon has expanded rapidly in Europe and Canada over the last 5–6 years and the lumpfish has become an economically important species. There are, however, health challenges associated with bacterial diseases. In recent years, there has been an increase in antibacterial treatments prescribed for this fish species despite a lack of knowledge regarding pharmacokinetics and effect of treatment with different antibiotics. The present study examined the uptake, tissue distribution, metabolism and elimination of the antibacterial agent florfenicol in lumpfish (Cyclopterus lumpus L.) following a single oral administration of 10 mg/kg fish given in feed. Plasma, head kidney, liver and muscle from six fish were sampled at each time point and analysed by liquid chromatography/mass spectrometry (LC-MS). Absorption was moderate for this drug characterised by a calculated peak plasma concentration (Cmax) of 3.55 μg/ml obtained after 21.2 hours (Tmax) and the elimination halflife (t1/2β) relatively extended in plasma at 30 hours. Area under curve (AUC) and AUC from 0 to 24 hours (AUC0-24h) were calculated to be 248 and 61 h μg/ml, respectively. Cmax was calculated to 2.99 μg/g in muscle, 2.54 μg/g in liver and 4.70 μg/g in head kidney with corresponding Tmax of 22.1, 26.4 and 19.4 h, respectively. The main metabolite, florfenicol-amine was found in low concentrations in plasma and all tissues examined. The minimum inhibition concentrations (MIC) for florfenicol of 28 of Aeromonas salmonicida isolates from diseased lumpfish ranged from 0.39 to 1.56 μg/ml. The pharmacokinetical data presented here make an important basis for efficient antibacterial treatment for lumpfish using florfenicol and for calculation of suitable withdrawal time. Knowledge of florfenicol pharmacokinetics, combined with determination of antibiotic resistance among fish pathogenic bacteria and the effect of antibacterial agents on diseased lumpfish in vivo are important for the welfare of lumpfish and prevention of resistant bacteria.en_US
dc.rightsAttribution-Non Commercial-No Derivatives CC BY-NC-NDeng
dc.subjectCyclopterus lumpuseng
dc.titlePharmacokinetics of florfenicol in lumpfish (Cyclopterus lumpus L.) after a single oral administrationen_US
dc.typePeer reviewed
dc.typeJournal article
dc.rights.holderCopyright 2019 The Authorsen_US
dc.relation.projectFiskeri- og havbruksnæringens forskningsfond: 901468
dc.relation.projectNorges forskningsråd: 244148

Files in this item


This item appears in the following Collection(s)

Show simple item record

Attribution-Non Commercial-No Derivatives CC BY-NC-ND
Except where otherwise noted, this item's license is described as Attribution-Non Commercial-No Derivatives CC BY-NC-ND